TDragon
11 Jan 2018
Re: Too ridiculous? Looks like a DEAD duck to me. Current value of shares makes it not worth the effort to sell. A massive disappointment.
pond1
10 Jan 2018
Re: Too ridiculous? Knowing how good the Deltex management team are, any tunnel would probably be circle shaped ending up where it started, leaving the potential escapees going round and round in circles, just like the company.Thank goodness EP wasn't in charge of the 'Great Escape' if he had been Steve McQueen would never have got near that motor bike.
susah lah
10 Jan 2018
Re: Too ridiculous? Probably just finishing off the escape tunnel...after all those 'jam tomorrow' announcements...well positioned, roll out with scale and pace, platforms for growth etc etc etc month after month and year after year...what a waste..
Fokisi
09 Jan 2018
Too ridiculous? From our angle, does it not seem rather too ridiculous for words, that current position exists?One can only assume there are frantic & final discussions going on behind the scenes, but who knows?Whole thing seems rather bizarre to me...
Carefully Does It
07 Jan 2018
Re: where did it all go wrong - some les... A note to self........Look for companies having a customer base reasembling a diverse investment portfolio.Too many eggs in one basket = keep a wide berth.
RAConnell
07 Jan 2018
Re: They think it's all over.... ............. well it is now?Cheers, RAC
susah lah
07 Jan 2018
They think it's all over.... Market has really gone to town on the latest update. The words carnage and bloodbath springs to mind and it's difficult to imagine this company pulling out of this latest nosedive. Time to pray and brace brace brace.....
Carefully Does It
06 Jan 2018
Re: where did it all go wrong - some les... I held Mediwatch years ago. Made money but that was another one struggling with the NHS but less so with small clinics.DEMG is twice handicapped as they are surgical procedure dependent that limits the market still further.
Carefully Does It
06 Jan 2018
Re: where did it all go wrong - some lessons Monolithic public sector end customers - avoid companies dependent on them.The NHS is extremely difficult to crack. Budget problems, multiple road blocks.Avoid like the plague.I had experience of a monolithic large private end customer that was a real struggle and they are a walk in the park compared to the NHS.A diverse customer base is less risky - not necessarily segment diversity but purchasing decision and budget control diversity. Lots of small private operators as targets can be much less risky than the NHS's yes/no (what looks attractive on the surface) honey pot.
Fokisi
05 Jan 2018
where did it all go wrong - some lessons "So much of this company is good - tech, intention, product.It's a great shame they have such an uphill struggle"There must be many, very useful lessons for us investors to learn from the Deltex storyI am trying to think what they areI welcome hearing what investors consider are those lessonsHere are some of mine:1. Leadership is (almost) everythingWith Deltex, sales growth was vitalI believe there was a power struggle for role of CEO at a critical time. Unfortunately it went to the candidate with a background in corporate finance, and not the candidate with a track record of sales expertise. EP did wonders developing a share bonus scheme and filled plenty of pages of dull reading in the Financial Statements. His success in delivering sales not so good2. Choose execs who target their sales strategy correctlyI believe unsuccessful CEO candidate proposed a sales strategy of US. EP eventually did, but too little too late3. Avoid CEO's who are serial issuer of sharesEP loved to use his corporate finance abilities to ensure new investors subscribed to further share issues4. Follow the Finance DirectorWhen the FD chooses to take up a role in another company, or spend more time with his family, likely best to withdraw your investment5. Choose a company which can replace its exec team if it does not perform
Carefully Does It
05 Jan 2018
So much good So much of this company is good - tech, intention, product.It's a great shame they have such an uphill struggle.
Carefully Does It
05 Jan 2018
Re: A case for the FCA? Well tax loss selling time zone is fast approaching, may offer a further down draught to the price.
seadoc
05 Jan 2018
Re: A case for the FCA? RAC,"Cheers, P.S. Where is seadoc?" Wales,Watching with interest for the potential funding plan. But 'tis a muddy puddle rather than a clear blue lagoon.Regards,Seadoc
pond1
05 Jan 2018
Re: A case for the FCA? Deltex have at least achieved something of note.......They are at the top of the losers board on the whole stock market. Well done EP.
RAConnell
05 Jan 2018
Re: A case for the FCA? Rats leaving the sinking ship but where are Keen and EP? Surely they are not part of any nefarious scheme. As to the 0.75p sale it could be EP's freebees but don't e.g. directors have to declare such a share sale?The mystery deepens.Cheers. RAC
